Companions Homecare acquired by Enara Group 

Acquirers in UK home care underwrite three things before price: regulatory standing, workforce stability, and the quality of the income. A clean registration and inspection history removes the single largest execution risk in the sector. Low carer turnover and a full rota matter because the acquirer is buying delivery capacity, not just a client list — a business that cannot staff its packages cannot bill them. On income, buyers separate privately funded hours from local authority-commissioned hours and assess fee rates, package continuity, and concentration across commissioners. A provider with a defensible position in a specific geography and the registrations to trade there is worth more to a consolidator than a larger business spread thinly across territories the acquirer already covers.

Domiciliary care is valued on a multiple of maintainable EBITDA, adjusted for owner remuneration, agency staffing costs, and any non-recurring items. The multiple itself is driven less by size than by risk: regulatory rating, carer retention, the private-versus-commissioned revenue split, and how much of the operation depends on the founder. Private pay hours generally support a stronger multiple than local authority hours because fee rates are higher and less exposed to commissioning cycles. Strategic buyers building geographic coverage will pay above the financial value of a business when it unlocks a territory they cannot otherwise reach, which is why identifying the right acquirer matters as much as the financial preparation. A competitive UK mid-market sell-side process is the reliable way to establish the maximum defensible valuation rather than accepting an inbound offer at its anchor.

UK domiciliary care remains a fragmented market of several thousand mostly owner-operated providers, while commissioning has consolidated around fewer, larger framework suppliers. That gap is the investment case. A backed platform can buy local providers at single-digit multiples, combine them under shared back-office, compliance, and recruitment infrastructure, and exit the enlarged group at a materially higher multiple — while the added scale improves its position in commissioning rounds. Enara's programme under August Equity is a clear worked example: control acquired in November 2008, £20m committed to acquisitions, roughly 50 bolt-ons completed by 2012, and a sale to Mitie for £110m in that year. For founders, the practical implication is that these buyers are only active in a given geography for a defined window, and value accrues to sellers who reach them inside it.

In a share sale, employment contracts continue unchanged; in a business and asset sale, TUPE regulations transfer staff on their existing terms. Beyond the legal position, platform acquirers have a direct commercial interest in retaining carers and continuity of visits, because the delivery capacity is the asset they have paid for and commissioners assess continuity when reviewing packages. What varies between buyers is what happens over the following 12 to 24 months as branches are integrated, rotas are re-planned, and back-office functions are centralised. Founders who care about this outcome should treat integration intent as a selection criterion during the process rather than a matter to raise at heads of terms, and should test each buyer on how previous acquisitions were handled.

Timing in care is set by three clocks running at different speeds. The regulatory clock is the shortest: a current, positive inspection outcome is a saleable position, and a pending or adverse one will pause a process. The consolidation clock is the one founders most often miss — backed acquirers enter a geography, buy, and then stop buying there, so the premium for a given territory exists for a period of perhaps 18 to 36 months. The personal clock is the founder's own capacity, which in care is closely tied to on-call burden and rota cover. Preparation typically takes 12 to 24 months: reducing founder dependency, stabilising the workforce, cleaning up management accounts, and confirming registrations. Founders who begin only once they are tired usually sell into the weakest of the three positions.

Regulatory standing shapes both the price and the deal structure. In a share sale the registration usually stays with the company, subject to notifying the regulator of changes in control and in the registered manager. In a business and asset sale the buyer must hold or obtain its own registration for the location, which adds time to completion and creates a real risk of a gap between signing and the ability to trade. Either route makes the registered manager one of the more commercially significant people in the transaction, and their retention is often negotiated directly. Buyers will examine inspection history, notifications, safeguarding records, and complaint handling in detail during due diligence. Resolving open regulatory issues before going to market is one of the few pre-sale actions in this sector with a direct, measurable effect on value.

The South East coast has favourable demographics for care demand and difficult economics for care delivery. An older-than-average population supports strong private pay volumes, while high housing costs, seasonal employment competition, and dispersed rural rounds make carer recruitment and travel time harder than in denser urban markets. Buyers price both sides of that. The other regional factor is buyer availability: the number of acquirers actively expanding into coastal East Sussex at any point is small, so a founder cannot assume a deep competitive field will appear on demand. Running a process that reaches the handful of genuinely relevant acquirers, at a point when their acquisition programmes are funded and open, is what creates competitive tension in a market of this size. Confidentiality matters more too — in a local market, word travels through commissioners and carers quickly.

Three tests separate advisors in this sector. First, buyer knowledge: can they name the acquirers currently building in your geography, and say where each is in its programme? Generic reach is not the same as knowing who is buying this quarter. Second, regulatory fluency: an advisor who understands registration transfer, registered manager retention, and how inspection history is diligenced will keep those issues from becoming price adjustments late in the process. Third, independence — an advisor with a standing relationship on the buy side is not negotiating only for you. Ask how many care transactions the individual leading your deal has personally completed, not the firm's aggregate. CapEQ is a Certified B Corporation, independently assessed against standards that include putting client outcomes ahead of deal income, and every engagement is led by a Partner who has owned and sold a business.